Meet Our Experts

At NanoMedX, our scientists and leaders are united by a single goal — delivering non-invasive gene therapies that transform lives.
With decades of expertise in biotech, research, and commercialization, we’re building tomorrow’s healthcare today.

Leadership & Scientific Advisory

Our Team

Meet the leadership and advisors pioneering our next-generation gene therapy platform.

Richard Boudreault
CEO

Leading our corporate strategy and growth with extensive biotech experience.
Affiliation: École Polytechnique de Montréal

Dr. Eli BenDavid
Founder

Expert in biomedical engineering, gene therapy, medical genetics, and precision-targeted nanomedicine delivery.
Affiliations: CHU de Québec and the Institute of Biomedical Engineering, Polytechnique Montréal

Ariel Cozocaru
Executive VP

Leading biotech partnerships and investor relations.

Dr. Jacques P. Tremblay
Neuroscientific Advisor

Expert researcher in neurodegenerative diseases, gene therapy, and RNA-based therapeutics.
Affiliations: Université Laval; Director of Molecular Medicine and Gene Therapy Laboratory, CHU de Québec

Dr. Marc Lavertu
Biomedical Engineering Advisor

Expert in biomedical engineering, biomaterials, and tissue engineering.
Affiliation: École Polytechnique de Montréal; Director of Biomaterial and Tissue Engineering Laboratory at the Institute of Biomedical Engineering

Dr. Avi Schroeder
Chemical Engineering Advisor

Expert in nanomedicine, targeted drug delivery, and personalized medicine.
Affiliation: Technion – Israel Institute of Technology; Director of Laboratory for Targeted Drug Delivery & Personalized Medicine Technologies

Dr. Nicolas Bertrand
Pharmacology Advisor

Expert in advancements in nanomedicine, pharmacology, and pharmaceutical nanoscience.
Affiliations: Université Laval; Director of NanoPharmacology and Pharmaceutical NanoScience Laboratory, CHU de Québec

Leadership

Dr. Richard Boudreault
CEO
Leading our corporate strategy and growth with extensive biotech experience.
‍
Affiliation: École Polytechnique de Montréal
Dr. Eli BenDavid
Founder, CTO, CMO
Leading our product engineering design & development, as well as clinical translation/applications.
Ariel Cozocaru
Executive VP
Leading our partnerships and investor relations.
Joel Rousseau
Director of Genetic Engineering
Leading our prime editors design and development

Board of Advisors

Dr. Jacques P. Tremblay
Neuroscientific Advisor
Expert researcher in neurodegenerative diseases, gene therapy, and RNA-based therapeutics.
‍
Affiliation: Université Laval; Director of Molecular Medicine and Gene Therapy Laboratory, CHU de Québec
Dr. Marc Lavertu
Biomedical Engineering Advisor
Expert in biomedical engineering, biomaterials, and tissue engineering.
‍
Affiliation: École Polytechnique de Montréal; Director of Biomaterial and Tissue Engineering Laboratory at the Institute of Biomedical Engineering
Dr. Avi Schroeder
Chemical Engineering Advisor
Expert in nanomedicine, targeted drug delivery, and personalized medicine.
‍
Affiliation: Technion – Israel Institute of Technology; Director of Laboratory for Targeted Drug Delivery & Personalized Medicine Technologies
Dr. Nicolas Bertrand
Pharmacology Advisor
Expert in advancements in nanomedicine, pharmacology, and pharmaceutical nanoscience.
‍
Affiliation: Université Laval; Director of NanoPharmacology and Pharmaceutical NanoScience Laboratory, CHU de Québec
Dr. Gary Zweiger
Scientific Advisor
Expert in Genetics and Biotech Venture Capital


Affiliation: RNA Advisors and Fluent BioSciences (an Illumina company)

Dr. Martin Ingelsson
Scientific Advisor
Expert in immunotherapy, gene therapy, and geriatrics


Affiliation: Krembil Research Institute, clinician-scientist at the Toronto Western Hospital / University Health Network